TickerRisk
Learn Pricing Open Scanner

BMY vs BSX: Options Risk Comparison

BRISTOL MYERS SQUIBB CO and BOSTON SCIENTIFIC CORP compared side by side — risk score, IV Rank, edge and earnings. Updated every 30 minutes.

MetricBMYBSX
Risk Score44100
Risk BandLOWHIGH
IV Rank50.5%42.9%
IV %29.8%40.9%
Edge Score+6-57
Price Δ+0.5%+0.1%
Next Earnings2026-07-302026-07-29
SectorHealth CareHealth Care

Which has higher options risk?

BOSTON SCIENTIFIC CORP (BSX) currently carries the higher options risk score (100 vs 44 for BMY) — meaning more active catalysts that can drive an overnight move. For selling option premium, BRISTOL MYERS SQUIBB CO (BMY) has the better edge score (+6) — a stronger blend of high IV Rank and low risk.

Risk score (0–100) reflects active catalysts — earnings, legal, SEC filings and news. Edge score = IV Rank − risk score; higher is better for selling premium.

Run a full scan on each — free

Scan BMY → Scan BSX →

BMY risk pages

More Health Care comparisons

TickerRisk provides risk scoring for informational purposes only. Not financial advice. Options trading involves substantial risk of loss. Full disclaimer